Healthcare AI GTM works when workflow becomes governable.
The commercial problem is no longer whether a model can generate an answer. It is whether a buyer can understand the evidence, implementation burden, decision rights, financial value, and risk.
Read current signalsSource dates remain visible. Public facts and operator interpretation are separated.
THE ENTERPRISE QUESTION
What changes after the model works?
The investment case must connect adoption, operating authority, exception handling and total cost to a result the organization can retain. Whole-care orchestration adds a further test: whether the improvement survives the next clinical, administrative and economic handoff.
Read the AI value-capture strategy ↗From use-case choice to a decision to scale
- Prioritize
Buyer urgency, economic value, data readiness, workflow fit, implementation burden, risk
- Architect
Product, data, integration, agents, evidence, exceptions, human review
- Build or buy
Requirements and vendor diligence; configure, integrate, build, partner, or stop
- Deploy
Bounded workflow; training, ownership, monitoring, escalation, security, change management
- Prove
Operating lift, quality, financial value, adoption, risk, total implementation cost
Policy to workflow
Government healthcare growth is an operating system.
Policy, procurement, claims operations, legal, product, sales and implementation must support the same commitment. A credible opportunity needs a purchasing route, a deliverable workflow and evidence the organization can defend.
No autonomous denial, referral, or patient-impact action should move without clear evidence, ownership, escalation logic, and human review.
The consulting operating model
The operating commitments behind an AI investment.
I structure the mandate around investment decisions: which workflow merits capital, what the organization should build or buy, and whether deployment changes the economics enough to justify expansion. Each stage should resolve an uncertainty before adding an irreversible commitment.
Prioritize
Rank use cases by buyer urgency, economic value, data readiness, workflow fit, implementation burden, and risk.
Explicit decision gateArchitect
Define the product, data, integration, agent, evidence, exception, and human-review model before tooling decisions harden.
Explicit decision gateBuild or buy
Create requirements and vendor-diligence criteria, then decide what should be configured, integrated, built, partnered, or stopped.
Explicit decision gateDeploy
Ship a bounded workflow with training, ownership, monitoring, escalation, security, and change management designed in.
Explicit decision gateProve
Measure operating lift, quality, financial value, adoption, risk, and total implementation cost before scaling.
Scale, redesign, or stopWhere this applies
Seven healthcare AI buying problems that need governance.
Each area connects a buyer problem to a defined workflow and evaluation plan. Automation earns a place when it improves that workflow within the required controls.
Healthcare AI consulting
Connect use-case strategy, workflow discovery, product and data architecture, implementation, adoption, governance, and measurable value.
Explore healthcare ai consultingAgentic RCM
Use agents to move evidence and exceptions through revenue workflows, with ownership and escalation made explicit.
Explore agentic rcmPayment integrity
Connect claims patterns, policy, provider impact, pre-payment logic, appeals, and savings proof.
Explore payment integrityPrior authorization
Treat denial reasons, documentation, API readiness, turnaround time, and access friction as one operating surface.
Explore prior authorizationClaims intelligence
Translate leakage, denial, and service-line patterns into buyer priorities and workflow intervention.
Explore claims intelligenceAI implementation
Move from workflow discovery and product design through integration, human handoff, evaluation, rollout, and adoption.
Explore ai implementationProduct and applications
Turn operating logic into usable portals, dashboards, APIs, decision tools, and field systems.
Explore product and applicationsCurrent market signals
Healthcare's operating rules are changing now.
These public signals show where founders and executives need stronger product, workflow, and proof architecture.
Agentic healthcare is moving into standards and workflow.
Public fact: ONC's 2026 LEAP funding opportunity includes standards-based agentic AI for clinical care and expanded FHIR endpoint monitoring.
My interpretation: Standards can reduce integration friction, but a deployable service still needs defined data access, decision authority and review capacity. Funding availability is a development signal, not evidence that the operating model works.
Prior authorization is becoming API infrastructure.
Public fact: CMS requirements now include decision timeframes, specific denial reasons, public metrics, and payer APIs scheduled for 2027 implementation.
My interpretation: Prior authorization becomes a measurable operating surface where access, revenue integrity, workflow, and provider trust can be managed together.
Regulated AI advantage starts with consolidated operating data.
Public fact: FDA announced Elsa 4.0 and HALO, consolidating more than 40 application and submission data sources for internal AI-enabled workflows.
My interpretation: Consolidated data can improve the conditions for automation. It does not establish the quality of an individual output or the economics of another institution’s deployment; those require separate evaluation.
Administrative friction is now a board-level economic problem.
Public fact: HHS reported more than five million federal payment disputes since the No Surprises Act process launched and finalized changes intended to reduce bottlenecks and costs.
My interpretation: Dispute volume makes documentation, recovery cost and cash timing relevant to capital allocation. A better process should be judged by resolved obligations and total cost, not by the number of submissions it can generate.
Discuss the strategic decision